{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:20:44Z","timestamp":1649096444643},"reference-count":14,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2019.1816","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T09:02:26Z","timestamp":1551258146000},"source":"Crossref","is-referenced-by-count":1,"title":["Substantial improvement in immune thrombocytopenic purpura associated with T-cell\/histiocyte-rich B-cell lymphoma treated with chemotherapy: A case report"],"prefix":"10.3892","author":[{"given":"Takatsugu","family":"Ogata","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe City Hospital Organization, Kobe, Hyogo 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kobe City Medical Center General Hospital, Kobe City Hospital Organization, Kobe, Hyogo 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Medical Center General Hospital, Kobe City Hospital Organization, Kobe, Hyogo 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kobe City Medical Center General Hospital, Kobe City Hospital Organization, Kobe, Hyogo 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe City Hospital Organization, Kobe, Hyogo 650-0047, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"key20200713202332_b1-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00296-002-0229-4","article-title":"Malignant lymphoma-associated autoimmune diseases - a descriptive epidemiological study","volume":"22","author":"V\u00e1r\u00f3czy","year":"2002","journal-title":"Rheumatol Int"},{"key":"key20200713202332_b2-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3324\/haematol.11934","article-title":"Autoimmune thrombocytopenia in non-Hodgkin's lymphomas","volume":"93","author":"Hauswirth","year":"2008","journal-title":"Haematologica"},{"key":"key20200713202332_b3-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1634\/theoncologist.11-4-384","article-title":"T-cell\/histiocyte-rich B-cell lymphoma: Biology, diagnosis, and management","volume":"11","author":"Abramson","year":"2006","journal-title":"Oncologist"},{"key":"key20200713202332_b4-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"key20200713202332_b5-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00277-013-1805-2","article-title":"Upregulation of innate immune responses in a T cell\/histiocyte-rich large B cell lymphoma patient with significant autoimmune disorders mimicking systemic lupus erythematosus","volume":"93","author":"Wu","year":"2014","journal-title":"Ann Hematol"},{"key":"key20200713202332_b6-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.thromres.2013.12.033","article-title":"Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy","volume":"133","author":"Asakura","year":"2014","journal-title":"Thromb Res"},{"key":"key20200713202332_b7-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12185-015-1854-5","article-title":"Disseminated intravascular coagulation in non-Hodgkin lymphoma","volume":"102","author":"Chi","year":"2015","journal-title":"Int J Hematol"},{"key":"key20200713202332_b8-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0145-2126(03)00253-4","article-title":"T-cell-rich B-cell lymphoma: A clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma","volume":"28","author":"Aki","year":"2004","journal-title":"Leuk Res"},{"key":"key20200713202332_b9-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.pai.0000132199.47017.35","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma displays a heterogeneity similar to diffuse large B-cell lymphoma: A clinicopathologic, immunohistochemical, and molecular study of 30 cases","volume":"13","author":"Wang","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20200713202332_b10-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1200\/JCO.2003.06.046","article-title":"T-cell\/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: A matched-control analysis","volume":"21","author":"Bouabdallah","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20200713202332_b11-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1200\/JCO.2002.20.5.1269","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma: A distinct clinicopathologic entity","volume":"20","author":"Achten","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20200713202332_b12-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/09537104.2010.517582","article-title":"Immune thrombocytopenic purpura occurred prior to multiple extranodal diffuse large B cell lymphoma","volume":"22","author":"Tan","year":"2011","journal-title":"Platelets"},{"key":"key20200713202332_b13-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2169\/internalmedicine.50.4848","article-title":"Diffuse large B-cell lymphoma complicated with autoimmune thrombocytopenia","volume":"50","author":"Uchiyama","year":"2011","journal-title":"Intern Med"},{"key":"key20200713202332_b14-mco-0-0-1816","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/hon.2048","article-title":"Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy","volume":"31","author":"Berrang","year":"2013","journal-title":"Hematol Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:23:38Z","timestamp":1594668218000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2019.1816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":14,"URL":"https:\/\/doi.org\/10.3892\/mco.2019.1816","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}